Effect of Garlic’s Active Constituents in Inflammation, Obesity and Cardiovascular Disease

• Published in: Current hypertension reports Vol. 22; no. 1; p. 6
• Main Authors: Quesada, Isabel, de Paola, Matilde, Torres-Palazzolo, Carolina, Camargo, Alejandra, Ferder, León, Manucha, Walter, Castro, Claudia
• Format: Journal Article
• Language: English
• Published: New York Springer US 2020; Springer Nature B.V
• Subjects: Atherosclerosis; Bioavailability; Cardiology; Cardiovascular disease; Chronic illnesses; Cytokines; Family Medicine; Garlic; General Practice; Hypertension; Hypertension and Obesity (E Reisin; Inflammation; Inflammatory diseases; Internal Medicine; Medicine; Medicine & Public Health; Metabolic Diseases; Nephrology; Obesity; Oxidative stress; Primary Care Medicine; Section Editor; Topical Collection on Hypertension and Obesity; Oxidative stress; Garlic; Mitochondria dysfunction; Organosulfur compounds; Atherosclerosis; Overweight
• ISSN: 1522-6417; 1534-3111
• DOI: 10.1007/s11906-019-1009-9

Purpose of Review Several studies have attributed garlic’s beneficial properties to its high content of organosulfur compounds (OSCs). Here, we summarized recent studies published and some own findings regarding OSCs and its effects on cardiovascular disease, inflammation, and obesity. Recent Finding The analysis of the multiple actions produced by OSCs suggests that many of its bioactivities interfere against inflammation, oxidative stress, obesogenic effects, and mitochondrial dysfunction. Accumulating evidence from in vitro, animal, and human studies reinforce the notion that OSCs modify signaling pathways that trigger chronic diseases, and to highlight, actions over these pathways are related to the treatment of disorders addressed in this review. Summary Garlic’s bioactive OSCs behave like a nutraceutical panacea because they cover a broad spectrum of applications with promising impact for the prevention and treatment of prevalent chronic pathologies associated with low-grade inflammation.